The projected increase in operating expenses for Sangamo Therapeutics could indicate an investment in research, development, or expansion, which might be viewed positively by investors as a sign of growth. However, the impact on the stock price is uncertain without knowing the specifics of the planned expenditures and their expected return on investment. The reliance on additional funding adds a layer of uncertainty.